University of Arkansas for Medical Sciences at AMP 2026
Nov 10–14, 2026 Seattle, WA ~2k attendees Website
University of Arkansas for Medical Sciences brings 2 presentations to AMP 2026 in Seattle. Its sessions centre on long-read sequencing, applied both to microbial identification and to brain tumour diagnostics. Topics include validated nanopore 16S and ITS sequencing for identifying cultured bacterial and fungal isolates, and what comes after methylation classification for brain tumours.
| Organization | AMP 2026 Attendance |
|---|---|
University of Arkansas for Medical Sciences Little Rock, AR | |
Public academic health centre in Little Rock with medical and pharmacy schools and clinical molecular diagnostics laboratories. | Poster Thu, Nov 12 3:15pm–3:30pm Talk Sat, Nov 14 2:30pm–3:00pm Beyond Methylation Classification: The Next Generation of Brain Tumor Diagnostics Through Long-Read Sequencing and Precision Oncology Brain tumour classification moving from methylation profiling toward long-read sequencing of genome, epigenome and transcriptome. |
Instantly find 20 buyers from University of Arkansas for Medical Sciences
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with the Association for Molecular Pathology. Organization details are derived from AMP’s published lists. Submit a correction